Home / AKUMS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AKUMS.NS make money? Does AKUMS.NS have pricing power? What's the Earnings Whisper? Will AKUMS.NS profit more as the business scales? What is AKUMS.NS's management track record? Is AKUMS.NS's current price justified?

Akums Drugs & Pharmaceuticals Ltd.

₹731 +$284.50 (+63.72%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹749.8

Day Range

₹728.7₹752.8

Year Range

₹409.3₹838.8

Market Cap

111.92B

AVG Volume

359.87K

Trailing/Forward PE

38.37/21.4

PEG ratio

0.65

Dividend Yield

0.41%

Next Earnings Date

2026-11-12

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

AKUMS.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
26 Q1	45.02B
25 Q4	43.59B
25 Q3	42.1B
25 Q2	40.6B
25 Q1	40.76B

Net Income (INR) · TTM

AKUMS.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
26 Q1	2.92B
25 Q4	2.55B
25 Q3	3.18B
25 Q2	3.17B
25 Q1	3.41B

Operating Income (INR) · TTM

AKUMS.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
26 Q1	4.09B
25 Q4	3.67B
25 Q3	3.13B
25 Q2	2.83B
25 Q1	3.13B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Akums Drugs & Pharmaceuticals Ltd.

Video analysis: AKUMS.NS

News: AKUMS.NS

Similar companies